Home Law \ Legal Latham & Watkins Advises Osler Diagnostics on Its US$85 Million Series C

Latham & Watkins Advises Osler Diagnostics on Its US$85 Million Series C

1 min read
Comments Off on Latham & Watkins Advises Osler Diagnostics on Its US$85 Million Series C
0
25

[ad_1]

Osler is a medical diagnostic company that has developed the Osler Origin – a portable diagnostic capable of performing a wide range of testing, with high-performance, in a rapid, low-cost, and easy-to-use manner. The Osler Origin will offer a wide portfolio of diagnostic tests and serve all major healthcare settings, globally.

The round included investment from a strategic investor, M&G Investments, and existing investors, including Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.

This investment will support Osler in advancing its Osler Origin product through regulatory activities, and towards market launch.

The Latham team was led by London corporate partner Robbie McLaren, with associates Aaron Bassett, Daria Les, Samantha Si, and Noreen Hesse.



[ad_2]

Source link

Load More Related Articles
Load More By 
Load More In Law \ Legal
Comments are closed.

Check Also

China’s Jan factory activity contracts at slower pace – Caixin PMI

[ad_1] Breadcrumb Trail Links PMN Business Article content BEIJING — China’s factory activ…